等待開盤 08-05 09:30:00 美东时间
+0.100
+8.00%
Captivision Inc. has secured approval from the Nasdaq Hearings Panel to continue listing on the Nasdaq, contingent on meeting certain conditions tied to its efforts to comply with the Periodic Filing Rule. The company is collaborating with its auditor, KPMG, to finalize restated financials and aims to submit its 2024 Annual Report by September 30, 2025. It must provide an audit update by August 29 and demonstrate full compliance by October 15. Wh...
07-29 12:00
2025 First Half HighlightsCM24 (α-CEACAM1 monoclonal antibody)Our Phase 2 dataset demonstrated strong objective response rates (ORR) in biomarker-enriched subgroups of second line PDAC patients, as outlined below. These
07-24 19:29
Captivision Inc. announced compliance with Nasdaq's market value and minimum bid price rules as of July 11, 2025. However, it remains non-compliant with Listing Rule 5250(c)(1) due to a delayed Form 20-F filing. The company plans to present its compliance plan at a July 22 hearing before the Nasdaq Panel. There is no assurance the Panel will grant further extensions or that compliance will be achieved by any extended deadline.
07-15 12:00
Captivision Inc. announces the successful completion of Phase One of a multi-phase LED signage installation project in partnership with digiLED and Canary Wharf Group. This milestone marks Canary Wharf's transformation into one of the world's most advanced digital commercial districts, featuring large-format digital billboards, interactive kiosks, and architectural LED signage. The project lays the foundation for a new era of communication and co...
06-27 12:00
Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced
06-23 19:06
Gainers Hong Kong Pharma Digital (NASDAQ:HKPD) shares increased by 25.6% to $2...
06-10 01:06
Captivision (NASDAQ:CAPT) received a letter from Nasdaq, stating it failed to regain compliance with the $50M market value requirement by the June 2 deadline. CAPT was previously notified of the defic...
06-07 04:39
Captivision Inc. (NASDAQ: CAPT) received a determination letter from Nasdaq on June 4, 2025, stating it failed to regain compliance with the $50 million Market Value of Listed Securities (MVLS) Requirement by June 2, 2025. The company previously had until June 2, 2025, to address this deficiency. Additionally, Nasdaq notified Captivision on May 22, 2025, that it had not filed its Form 20-F for the period ended December 31, 2024, violating Listing...
06-06 20:30
Gen Protects Millions of People as Breached Personal Information, Phishing Reports, Fake Browser Update Scams, and Scam-Yourself Attacks Are on the Rise TEMPE, Ariz. and PRAGUE, May 28, 2025...
05-28 21:00